Grants and Awards

We highly value creativity, initiative and innovation. So, it’s very important to us that we recognize scientists, students and entrepreneurs who exhibit these qualities in outstanding work.


Emanuel Merck Lectureship

The Emanuel Merck Lectureship was established in 1992 and is given in partnership with Technical University, Darmstadt, Germany. It recognizes globally renowned scientists for outstanding contributions to chemical and pharmaceutical research. Learn more

Global Grants for Medical Education

In order to promote advances in the field of medicine, we offer grants to independent medical education providers to design and deliver advanced medical training across the world enhancing medical practice for the ultimate benefit of patients. Learn more

Future Insight Prize

Stimulating scientific and technological progress in the areas of health, nutrition, and energy. Learn more

Biopharma Innovation Cup

Join the brightest students from all over the world for a week at the company headquarters. Learn from professionals, network, develop a business plan, and win a team prize! Learn more

Emerging Biotech Grant Program

We understand the challenges emerging biotech companies face in the quest to push the next generation of drugs to market. This is why we have developed our EB Grant programs that we run on a regular basis in different regions of the world. These programs allow grant recipients to receive free products and services. Learn more

Displaying Futures Award

With this award we recognize breakthrough ideas and entrepreneurial spirit in the field of Performance Materials. The winning teams receive extensive funding and mentorship from our experts to further explore and develop their idea. Learn more

Latest News on Grants and Awards

View All News

Press Releases

MilliporeSigma Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

MilliporeSigma today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative.

2019/05/20

Press Releases

FDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Combination for Patients ...

Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) ...

2019/05/14

Press Releases

European Space Agency and Merck KGaA, Darmstadt, Germany, Expand Cooperation

Merck KGaA, Darmstadt, Germany, and the European Space Agency (ESA) today signed a Letter of Intent to extend by a further two years their cooperation agreement from 2016.

2019/05/02

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement